117 related articles for article (PubMed ID: 12097718)
1. Bioterrorism today.
Snell N
Biologist (London); 2002 Jun; 49(3):140. PubMed ID: 12097718
[TBL] [Abstract][Full Text] [Related]
2. Responding to anthrax.
Borg MA; Tieck WC
J Dent Technol; 2001; 18(8):12-4, 28. PubMed ID: 11885187
[No Abstract] [Full Text] [Related]
3. Into the zone of the unknown. It's been the blind leading the blind through the maze of anthrax.
Shute N; Spake A
US News World Rep; 2001 Nov; 131(19):40-1, 44-6, 47 passim. PubMed ID: 11710269
[No Abstract] [Full Text] [Related]
4. What is the true number of victims of the postal anthrax attack of 2001?
Cymet TC; Kerkvliet GJ
J Am Osteopath Assoc; 2004 Nov; 104(11):452. PubMed ID: 15602039
[No Abstract] [Full Text] [Related]
5. Lessons learned from the CDC's post-exposure prophylaxis program following the anthrax attacks of 2001.
Bresnitz EA
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):389-91. PubMed ID: 15924332
[No Abstract] [Full Text] [Related]
6. Bioterrorism: a clear and present danger.
Lane HC; Montagne JL; Fauci AS
Nat Med; 2001 Dec; 7(12):1271-3. PubMed ID: 11726956
[No Abstract] [Full Text] [Related]
7. Our first line of defense against bioterrorism part 2.
Simpson RL
Nurs Manage; 2002 May; 33(5):10, 11. PubMed ID: 12006878
[TBL] [Abstract][Full Text] [Related]
8. A dose of reality for the health watchdogs.
Kluger J
Time; 2001 Oct; 158(19):65-6. PubMed ID: 11699134
[No Abstract] [Full Text] [Related]
9. Bioterrorism watch. Building a bridge over the abyss: will bioterrorism help bring disjointed health system together?
Evans G
Hosp Peer Rev; 2002 Apr; 27(4):suppl 1-2. PubMed ID: 11951727
[No Abstract] [Full Text] [Related]
10. Anthrax bioterrorism: lessons learned and future directions.
Hughes JM; Gerberding JL
Emerg Infect Dis; 2002 Oct; 8(10):1013-4. PubMed ID: 12396907
[No Abstract] [Full Text] [Related]
11. Ethics and bioterrorism research.
Bull Med Ethics; 2004 May; (198):13-20. PubMed ID: 15832477
[No Abstract] [Full Text] [Related]
12. CDC: be alert to symptoms associated with bioterrorism.
Levenson D
Rep Med Guidel Outcomes Res; 2001 Nov; 12(21):1-2, 5. PubMed ID: 12382635
[No Abstract] [Full Text] [Related]
13. Project Bioshield: protecting Americans from terrorism.
Meadows M
FDA Consum; 2004; 38(6):32-3. PubMed ID: 15675025
[No Abstract] [Full Text] [Related]
14. Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax.
Tierney BC; Martin SW; Franzke LH; Marano N; Reissman DB; Louchart RD; Goff JA; Rosenstein NE; Sever JL; McNeil MM;
Clin Infect Dis; 2003 Oct; 37(7):905-11. PubMed ID: 13130401
[TBL] [Abstract][Full Text] [Related]
15. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
Mayer TA; Morrison A; Bersoff-Matcha S; Druckenbrod G; Murphy C; Howell J; Hanfling D; Cates R; Pauze D; Earls J
Clin Infect Dis; 2003 May; 36(10):1275-83. PubMed ID: 12746773
[TBL] [Abstract][Full Text] [Related]
16. Booming biosafety labs probed.
Wadman M
Nature; 2009 Oct; 461(7264):577. PubMed ID: 19794463
[No Abstract] [Full Text] [Related]
17. Bioterrorism watch. Anthrax aftermath: adverse drug reactions, vaccine controversy undercut CDC extended treatment offer.
Evans G
Hosp Peer Rev; 2002 Mar; 27(3):suppl 1-4. PubMed ID: 11905387
[No Abstract] [Full Text] [Related]
18. Secret service.
Nature; 2015 Jul; 523(7562):501-2. PubMed ID: 26223588
[No Abstract] [Full Text] [Related]
19. Veterinarians key to bioterrorism preparedness initiatives.
Kuehn BM
J Am Vet Med Assoc; 2002 Sep; 221(6):757-8. PubMed ID: 12322902
[No Abstract] [Full Text] [Related]
20. Anthrax aftermath: adverse drug reactions, vaccine controversy undercut CDC extended treatment offer.
Evans G
ED Manag; 2002 Mar; 14(3):suppl 1-4. PubMed ID: 11912887
[No Abstract] [Full Text] [Related]
[Next] [New Search]
